Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

Market Cap	16.78B
Revenue (ttm)	1.71B
Net Income (ttm)	163.14M
Shares Out	928.16M
EPS (ttm)	0.18
PE Ratio	101.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,438,238
Average Volume	12,527,413
Open	18.50
Previous Close	18.08
Day's Range	17.81 - 19.79
52-Week Range	8.33 - 19.79
Beta	0.33
RSI	62.22
Earnings Date	Apr 28, 2025

About SHE:002755

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 979
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002755

Financial Performance

In 2023, SHE:002755's revenue was 1.44 billion, a decrease of -22.92% compared to the previous year's 1.87 billion. Losses were -148.53 million, -34.23% less than in 2022.